Mission Statement

ASCO AI in Oncology serves as a central resource for trusted news about artificial intelligence in cancer care to support the safe, effective, and equitable integration of artificial intelligence into multidisciplinary clinical practice.

About

ASCO AI in Oncology is a digital-only platform—from Conexiant, publisher of The ASCO Post, in partnership with the American Society of Clinical Oncology (ASCO)—for keeping oncology professionals and ASCO members informed amid the rapidly evolving landscape of artificial intelligence use in oncology practice. The platform combines reporting of leading research and conference coverage with expert clinical insights and practical education for a broad view of the technological advancements impacting the oncology field. 

The editorial team of ASCO AI in Oncology is led by an editorial advisory board of experts in various areas of cancer care and artificial intelligence. 

Empowering Oncology Professionals Through AI Insight and Collaboration

Centralized, Trusted Intelligence

Coverage of oncology research in AI is driven by peer-reviewed publications—ensuring quality you can count on.

Dynamic Education and Engagement

ASCO AI in Oncology will feature interactive programs designed to advance knowledge and professional development.

A Community for the Future of Oncology

ASCO AI in Oncology offers healthcare professionals a place to share their opinions and insights on AI uses and impacts across disciplines and institutions, fostering a culture of collaboration.